Home
About the PCRJ
Aims, Scope and History
Editorial Board
Online first
Current Issue
education@pcrj
Past Issues
Supplements
Translations
Most popular articles
Alerts
Subscribe
Instructions for Authors
Advertising
Disclaimer and Legal Notices
Contact Us
PDF View full text as PDF document

CrossRef Right click on this DOI link and copy link/shortcut to cite this article (What is a DOI link?)

Export Export to bibliographic software or plain text

CiteULike Post to CiteULike

Email this article Email this article to friend/s or colleague/s

Cited by Cited by
•   Back to table of contents

Volume 20 Issue 2 June 2011

Guideline Summary

Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis

Pages 135-140
*Adam T Hilla, Mark Pasteurb, Charles Cornfordc, Sally Welhamd, Diana Biltone

a Department of Respiratory Medicine, Royal Infirmary and University of Edinburgh, Scotland, UK

b Department of Respiratory Medicine, Norfolk and Norwich University Hospital, Norwich, UK

c Fulcrum Medical Practice, Middlesbrough, UK

d British Thoracic Society, London, UK

e Department of Respiratory Medicine, Royal Brompton Hospital, London, UK

Received 9 July 2010 • Accepted 22 November 2010 • Online 18 February 2011


Abstract
The British Thoracic Society (BTS) has recently published a guideline for the management of non-cystic fibrosis (non-CF) bronchiectasis in children and adults. This paper summarises the key recommendations applicable to the primary care setting. The key points are: • Think of the diagnosis of bronchiectasis in adults and children who present with a chronic productive cough or unexplained haemoptysis, and in children with asthma which responds poorly to treatment; • High resolution computed tomography (HRCT) scanning is needed to confirm the diagnosis • Sputum culture should be obtained at the start of an exacerbation prior to initiating treatment with antibiotics; Treatment should be started whilst awaiting the sputum result and should be continued for 14 days; • Patients with bronchiectasis have significant morbidity. Management in primary care is aimed at improving morbidity, and includes; patient education, treatment and monitoring, as well as appropriate referral to secondary care including assessment for long term antibiotics.

Cite as: Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J 2011;20(2):135-140. DOI: http://dx.doi.org/10.4104/pcrj.2011.00007

Keywords
Guideline, infection, bronchiectasis, BTS, summary, primary care, diagnosis, patient education, treatment, monitoring

* Corresponding author. Adam T Hill Tel: +44 (0)131 242 1921 Fax: +44 (0)131 242 1870 Email: adam.hill2@nhs.net